Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Everbright ( (HK:0165) ) just unveiled an announcement.
China Everbright Limited announced that non-executive director Dr. Qin Hongyuan has resigned from the board and from the Environmental, Social and Governance Committee, effective 26 March 2026, due to work arrangements. The company emphasized that Dr. Qin has no disagreement with the board and that there are no matters related to his departure requiring shareholder attention, suggesting the move is administrative rather than signaling governance or strategic tensions, though it does create a vacancy in its ESG oversight structure.
The board expressed appreciation for Dr. Qin’s dedication and diligence during his tenure, underscoring his contributions to the group’s governance. The announcement also reiterates the current composition of the board, indicating continuity in the company’s leadership framework despite the change and aiming to reassure investors and other stakeholders about stability at the senior oversight level.
The most recent analyst rating on (HK:0165) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on China Everbright stock, see the HK:0165 Stock Forecast page.
More about China Everbright
China Everbright Limited is a Hong Kong–incorporated investment company listed on the Stock Exchange of Hong Kong. Through its subsidiaries, the group focuses on diversified financial services and investment management across Mainland China and Hong Kong, positioning itself as part of the broader Chinese state-linked financial and asset management sector.
Average Trading Volume: 5,980,420
Technical Sentiment Signal: Sell
Current Market Cap: HK$12.89B
For a thorough assessment of 0165 stock, go to TipRanks’ Stock Analysis page.